Results 161 to 170 of about 32,996 (302)
Biological Sex and Chronic Rhinosinusitis Diagnosis and Biomarkers. [PDF]
Chiu RG +7 more
europepmc +1 more source
Association between body composition indices and prevalence of chronic rhinosinusitis in Koreans
K. Lee +3 more
openalex +2 more sources
The Need to Promote Olfactory Health in Public Health Agendas Across the Globe
ABSTRACT Background A good sense of smell is essential for physical and mental health, and social wellbeing; however, across the globe, regardless of the setting, national public health agendas never consider smell health. This review aims to summarise the wide‐reaching impact of smell health in public health. Methods Narrative review of the literature
Carl Martin Philpott +5 more
wiley +1 more source
Chronic rhinosinusitis is a risk factor for interstitial lung disease in Sjogren's syndrome. [PDF]
Schonewald B +4 more
europepmc +1 more source
Feasibility of Treating Eosinophilic Chronic Rhinosinusitis Using Short-Chain Fatty Acids. [PDF]
Epithelial cell‐derived cytokines including thymic stromal lymphopoietin (TSLP) are important in the pathogenesis of chronic rhinosinusitis with nasal polyps. We demonstrate the inhibitory effect of TSLP production in airway epithelial cells and eosinophil survival by short‐chain fatty acids (SCFAs) as a potential new strategy to reduce nasal polyps ...
Gozawa R +12 more
europepmc +2 more sources
The treatment of patients with chronic rhinosinusitis in the conditions of sanatorium and preventive measures [PDF]
S. I. Pshenichnyi +2 more
openalex +1 more source
ABSTRACT Objective To identify sociodemographic and clinical predictors of symptom severity and quality of life (QoL) impairment in patients with chronic rhinosinusitis with nasal polyps (CRSwNP), diagnosed according to the latest EPOS 2020 criteria. Study Design Cross‐sectional analytical study.
Javier Modesto García‐Fernández +5 more
wiley +1 more source
ABSTRACT Background Conjunctivitis is among the most frequent adverse events (AEs) emerged in clinical trials for all biologic drugs approved for atopic dermatitis (AD). However, real‐world comparative data on the incidence, risk factors, and management of conjunctivitis remain limited.
Luca Potestio +50 more
wiley +1 more source
High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy. [PDF]
ABSTRACT Objective This study aimed to evaluate the clinical remission rate and changes in medication use in patients with eosinophilic chronic rhinosinusitis (ECRS) treated with dupilumab for > 2 years. Methods This retrospective study included 19 patients with ECRS who received dupilumab therapy for > 2 years. The nasal polyp, Lund–Mackay on sinus CT,
Kamimura S +4 more
europepmc +2 more sources

